大豆油联合膜剥离术与口服米索前列醇用于引产的前瞻性观察研究
Castor oil plus sweeping membrane maneuver versus oral misoprostol for labor induction: a prospective observational study
一项前瞻性观察研究比较了169名足月孕妇使用大豆油联合膜剥离术与口服米索前列醇用于引产的效果。结果显示,两组在24小时内进入活跃产程的比例相近,但联合策略组的额外医疗干预使用率较低。尽管未发现显著差异,联合策略组的产程中干预使用较少,但仍需更大规模的随机对照试验来评估临床结局、安全性和成本。
- Article
- Open access
- Published: 31 October 2026
- Ciabatti Francesca1,
- Marzero Alessia1,
- Massicci Eleonora1,
- Moretti Laura1,
- Squeri Pietro2,
- Osella Francesca1,
- Roero Sofia1,
- Arduino Silvana1 &
- …
- Revelli Alberto1
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Labor induction is a common procedure in obstetric practice, required to terminate pregnancy in several clinical conditions. Oral prostaglandins are frequently used, but require close monitoring of maternal-fetal well-being. Combination of oral castor oil administration plus membrane sweeping maneuver could represent an initial strategy, but its comparative effectiveness and resource implications require further evaluation. A prospective observational study was conducted on 169 term pregnant women indicated for labor induction: 100 received 60 mL oral castor oil plus membrane sweeping (combined strategy); 69 received oral misoprostol. Primary outcome was active labor onset within 24 h; other outcomes included maternal-fetal safety parameters, induction-to-delivery time and secondary medical interventions. Labor onset within 24 h was achieved in 54/100 patients (54.0%) of the combined strategy group versus 37/69 patients (53.6%) of the misoprostol group. The crude risk difference was + 0.38% points (95% CI − 14.51 to + 15.37), while the adjusted risk difference was − 2.59% points (95% bootstrap CI − 17.97 to + 14.31). Given a no difference detected in induction-to-delivery interval, the combined strategy was associated with a significantly less use of secondary medical interventions (oxytocin use, amniorexis, epidural analgesia). Overall, delivery mode and neonatal outcomes were comparable; the misoprostol group had a higher incidence of meconium-stained amniotic fluid (5,0% versus 13,0%), but the association was exploratory. Crossover to misoprostol was described as a treatment pathway and was not used to infer comparative efficacy. This prospective observational study did not detect a difference in the proportion of women entering active labor within 24 h between the two initial strategies; however, the study was not designed to establish equivalence or non-inferiority. Lower use of some intrapartum interventions was observed in the combined strategy group, but residual confounding cannot be excluded. Larger randomized studies should assess clinical outcomes, safety and costs.
Acknowledgements
The authors express their sincere gratitude to all the midwives of the Gynecology and Obstetrics 2 at City of Health and Science-S. Anna University Hospital for their outstanding support, cooperation, and dedication throughout the course of this study.
Funding
The authors declare that no financial support was received for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Department of Surgical Sciences, Gynecology and Obstetrics 2, City of Health and Science-S. Anna University Hospital, University of Turin, 10126, Turin, Italy
Ciabatti Francesca, Marzero Alessia, Massicci Eleonora, Moretti Laura, Osella Francesca, Roero Sofia, Arduino Silvana & Revelli Alberto
Institute of Materials for Electronics and Magnetism (IMEM)-National Research Council of Italy (CNR), Parco Area delle Scienze 37A, 43124, Parma, Italy
Squeri Pietro
Authors
- Ciabatti Francesca
- Marzero Alessia
- Massicci Eleonora
- Moretti Laura
- Squeri Pietro
- Osella Francesca
- Roero Sofia
- Arduino Silvana
- Revelli Alberto
Corresponding author
Correspondence to Ciabatti Francesca.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The study was approved by the Territorial Ethics Committee of Turin (A.O.U. Città della Salute e della Scienza di Torino, Protocol No. 0099596) and adhered to the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Francesca, C., Alessia, M., Eleonora, M. et al. Castor oil plus sweeping membrane maneuver versus oral misoprostol for labor induction: a prospective observational study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-77737-6
Received: 21 July 2026
Accepted: 21 October 2026
Published: 31 October 2026
DOI: https://doi.org/10.1038/s41598-026-77737-6
Keywords
来源:Nature 健康护理主题 · nature.com